JC Xu
Chief Tech/Sci/R&D Officer chez ADAGENE INC.
Profil
JC Xu is currently the Chief Scientific Officer at Adagene, Inc. Prior to this, she worked as the Head of Research at Bristol Myers Squibb Co. from 2017 to 2020.
From 2012 to 2017, she worked as the Biology Director at Quanticel Pharmaceuticals, Inc. and before that, she worked as the Director of Strategy & Operations at Celgene Quanticel Research, Inc. Dr. Xu holds a doctorate degree from The University of Alabama at Birmingham and another doctorate degree from Peking University Health Science Center.
Postes actifs de JC Xu
| Sociétés | Poste | Début |
|---|---|---|
| ADAGENE INC. | Chief Tech/Sci/R&D Officer | 01/08/2020 |
Anciens postes connus de JC Xu
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Quanticel Pharmaceuticals, Inc.
 Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Quanticel Pharmaceuticals, Inc. engaged in the development of medicines for the treatment of cancer. The company was founded by Stephen Quake and Michael Clarke in 2010 and was headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/01/2017 |
Celgene Quanticel Research, Inc.
 Celgene Quanticel Research, Inc. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Quanticel Research, Inc. provides research and development for American biopharmaceutical company. | Corporate Officer/Principal | - |
Formation de JC Xu
| The University of Alabama at Birmingham | Doctorate Degree |
| Peking University Health Science Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ADAGENE INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Quanticel Pharmaceuticals, Inc.
Quanticel Pharmaceuticals, Inc. BiotechnologyHealth Technology Quanticel Pharmaceuticals, Inc. engaged in the development of medicines for the treatment of cancer. The company was founded by Stephen Quake and Michael Clarke in 2010 and was headquartered in San Francisco, CA. | Health Technology |
Celgene Quanticel Research, Inc.
Celgene Quanticel Research, Inc. BiotechnologyHealth Technology Part of Bristol Myers Squibb Co., Celgene Quanticel Research, Inc. provides research and development for American biopharmaceutical company. | Health Technology |
